rfhg_219813.1

Basic information about the TSS

---

TSS ID: rfhg_219813.1 TSS ID(Version3): hg_187020.1 hg_187019.1 hg_228178.1 Species: human Chr: chr20		Start: 35092786 End: 35092850 Strand: -
Source datasets	FANTOM5|PRJNA615891|PRJNA597322|PRJDB5282|PRJNA548673 |PRJNA401781|PRJNA4843412|DRA013844
Protocol	CAGE|TIF-seq2|STRIPE-seq|C1CAGE|ReCappable-seq|SLIC_CAGE |NETCAGE
TSS cluster detected*	10

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3294603,EH38E2108920)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000451813.6:0 ENST00000252015.3:0 AK074106:0 AK303476:0 AK298958:0 AK315582:0 GeneID: 26133 HGNC/MGI_ID: HGNC:16181 UniProt_ID: B2RDK8 B4DQU2 B4E0Q1 Q8TEL6 Nearer transcript ids and distances: BC013144:2 JF432334:4 KJ898597:4 AB590540:4 CU680522:4 view more...

Gene_name: transient receptor potential cation channel subfamily C member 4 associated protein Gene_symbol: TRPC4AP Gene_synonyms: DKFZP727M231 DKFZp586C1223 PPP1R158 TRRP4AP dJ756N5.2 Gene_source: HGNC:16181

TATA-Box annotation

---

Distance to TSS:	-3
Nearest PromoterID:	NM_199368
Entrez ID:	26133
Nearest Unigene:	Hs.168073
Nearest Refseq:	NM_015638
Nearest Ensembl:	ENSG00000100991
Gene Name:	transient receptor potential cation channel subfamily C member 4 associated protein
Gene Alias:	C20orf188|PPP1R158|TRRP4AP|TRUSS
Gene Type:	protein-coding
CpG%:	0.140625
GC%:	0.692308
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TRPC4AP p2@TRPC4AP p3@TRPC4AP p4@TRPC4AP
Sample		p1@TRPC4AP	p2@TRPC4AP	p3@TRPC4AP	p4@TRPC4AP
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	47.92	0.78	0.00	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	47.34	0.61	0.00	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	57.29	1.35	0.39	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	43.45	0.62	0.42	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	52.42	1.35	0.45	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	53.10	0.78	0.00	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	76.69	1.74	0.44	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	55.23	1.70	0.00	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	67.32	1.07	0.00	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	89.26	1.74	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	83.27	2.02	0.40	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	89.85	2.03	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	72.05	1.45	0.64	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	67.66	2.26	0.60	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	73.77	1.10	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	52.31	1.26	1.01	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	54.60	1.09	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	49.77	0.84	0.00	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	59.71	2.67	1.07	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	70.71	1.35	0.45	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	70.03	1.60	0.13	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	67.32	1.21	0.52	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	60.36	1.03	0.52	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	65.28	1.94	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	67.85	1.03	0.00	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	66.78	0.95	0.63	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	59.89	0.55	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	62.95	1.41	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	59.60	0.48	0.81	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	58.81	1.09	1.45	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	56.31	1.47	0.00	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	58.81	1.17	0.59	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	65.63	0.63	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	60.04	1.81	0.49	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	60.58	0.93	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	56.72	1.15	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	61.31	1.43	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	51.38	1.21	0.60	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	53.75	1.62	0.27	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	60.74	0.72	1.44	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	54.34	1.41	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	62.22	0.73	0.29	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	53.99	0.42	0.63	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	56.12	1.57	0.17	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	56.42	1.20	1.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	60.26	1.63	1.40	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	57.10	2.64	0.48	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	53.35	2.09	1.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	65.59	1.20	1.20	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	66.93	1.62	1.42	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	82.39	2.05	1.02	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	80.94	1.78	0.44	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	125.93	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	47.20	2.13	1.42	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	61.64	0.99	1.99	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	45.30	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	68.89	1.84	1.38	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	50.56	1.62	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	59.74	0.64	1.61	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	96.81	3.46	0.63	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	38.78	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	49.35	1.12	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	81.21	1.59	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	78.49	0.68	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	62.38	1.95	0.32	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	46.86	0.35	0.00	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	86.87	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	56.06	0.98	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	57.52	0.99	0.50	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	63.80	0.47	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	91.41	2.98	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	56.92	1.24	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	56.26	0.31	0.61	0.31
Adipocyte - breast, donor1	11376-118A8	81.25	2.22	0.48	0.79
Adipocyte - breast, donor2	11327-117E4	44.60	2.09	0.16	0.48
Adipocyte - omental, donor1	11473-119C6	78.75	2.29	0.89	0.25
Adipocyte - omental, donor2	11474-119C7	72.51	0.00	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	48.56	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	53.59	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	31.89	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	56.00	1.35	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	56.65	2.26	0.35	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	93.09	2.15	0.78	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	65.89	1.54	0.77	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	79.73	1.12	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	101.69	0.59	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	82.85	1.93	0.24	0.88
Adipocyte differentiation, day08, donor2	13023-139D8	74.23	1.61	0.32	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	43.72	1.07	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	78.46	0.56	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	58.64	0.83	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	60.78	1.00	0.25	2.26
Adipocyte differentiation, day12, donor3	13027-139E3	57.27	1.31	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	56.63	1.83	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	97.02	0.66	0.22	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	64.54	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	47.92	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	73.58	1.62	0.18	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	80.33	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	71.29	0.41	0.62	1.03
Anulus Pulposus Cell, donor1	11248-116E6	82.50	2.75	0.57	0.69
Anulus Pulposus Cell, donor2	11463-119B5	77.88	0.00	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	62.00	0.90	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	66.86	0.87	1.30	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	42.80	4.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	63.67	1.49	1.49	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	45.53	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	56.11	1.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	53.28	0.65	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	60.19	0.97	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	52.26	1.78	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	59.89	1.51	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	68.94	2.90	0.73	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	52.66	2.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	76.93	1.81	0.33	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	72.33	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	63.03	3.32	0.45	1.66
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	75.01	1.61	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	55.36	1.13	0.00	1.32
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	56.13	3.21	0.27	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	53.65	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	56.23	1.49	0.50	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	46.83	3.60	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	92.04	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	57.81	1.20	1.03	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	92.29	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	69.42	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	55.40	0.76	0.38	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	62.99	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	55.86	1.71	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	65.84	1.50	0.43	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	58.07	1.29	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	50.67	2.35	0.00	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	53.06	0.64	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	45.66	2.14	0.00	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	50.89	2.34	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	50.28	3.01	0.90	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	48.71	3.56	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	63.57	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	49.41	2.55	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	47.65	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	69.48	1.73	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	52.29	0.42	0.85	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	47.27	1.74	0.00	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	44.40	1.89	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	50.01	0.85	0.85	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	50.96	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	97.18	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	54.03	1.07	0.86	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	49.34	0.60	1.20	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	61.96	1.46	0.73	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	51.26	0.92	0.23	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	45.91	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	68.39	2.29	0.76	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	59.04	1.45	1.24	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	62.42	1.22	0.61	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	69.31	0.96	0.96	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	62.75	2.22	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	61.03	3.05	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	67.57	0.55	2.22	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	71.23	1.59	0.26	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	66.15	0.73	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	100.22	0.98	1.47	0.86
Astrocyte - cerebellum, donor2	11580-120F5	96.88	0.68	0.51	1.03
Astrocyte - cerebellum, donor3	11661-122F5	85.16	2.10	1.26	1.47
Astrocyte - cerebral cortex, donor1	11235-116D2	76.34	1.39	0.35	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	68.92	2.43	0.49	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	73.69	1.94	0.89	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	56.65	0.11	0.11	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	56.38	1.00	0.38	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	56.56	0.68	0.23	0.68
Basophils, donor1	12241-129G9	105.92	1.05	0.00	0.00
Basophils, donor2	12242-129H1	167.41	2.16	0.72	0.36
Basophils, donor3	12243-129H2	101.43	0.59	0.59	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	51.10	1.08	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	40.69	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	86.08	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	57.12	0.63	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	75.90	0.83	0.42	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	51.12	0.23	0.92	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	33.65	1.08	0.18	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	65.03	0.41	0.10	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	96.19	1.16	0.23	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	106.17	0.32	0.64	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	134.45	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	117.22	1.13	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	96.70	0.19	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	110.65	0.66	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	118.88	0.85	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	112.21	0.76	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	107.83	0.00	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	143.54	0.58	0.00	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	115.57	0.30	0.00	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	147.35	0.71	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	100.94	0.84	0.00	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	90.81	0.55	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	118.76	0.25	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	119.83	0.00	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	139.23	0.53	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	149.73	0.00	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	98.57	0.47	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	106.13	0.53	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	109.83	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	106.21	0.59	0.15	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	99.97	0.20	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	121.59	0.62	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	92.20	0.23	0.00	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	104.05	0.45	0.45	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	82.49	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	151.98	0.27	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	168.35	0.87	0.52	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	167.49	0.42	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	90.02	0.37	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	96.17	0.00	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	92.13	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	116.13	0.70	0.35	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	118.94	0.74	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	147.87	0.86	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	95.41	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	91.10	0.46	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	108.57	0.70	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	76.72	0.65	0.44	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	106.49	0.00	0.92	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	80.15	0.43	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	127.69	0.62	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	121.20	0.52	0.35	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	145.38	0.67	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	102.07	0.51	0.51	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	115.05	1.10	0.22	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	100.22	0.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	126.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	112.54	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	118.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	121.00	1.60	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	122.76	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	123.54	0.70	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	133.34	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	119.96	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	143.83	0.82	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	100.83	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	92.38	0.00	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	70.71	2.42	0.81	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	61.92	1.60	0.40	0.80
CD34+ Progenitors, donor1	11545-120B6	122.49	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	170.79	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	83.79	0.75	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	107.33	2.03	1.13	0.45
CD4+ T Cells, donor1	11225-116C1	162.82	1.43	1.07	0.36
CD4+ T Cells, donor2	11306-117C1	131.05	0.00	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	110.71	1.83	0.30	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	118.68	1.79	0.51	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	131.39	1.35	0.90	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	126.77	2.87	1.44	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	155.98	1.42	0.47	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	193.84	1.40	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	154.92	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	113.73	0.87	0.29	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	106.25	2.20	0.68	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	119.94	0.48	0.16	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	144.80	0.90	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	147.09	1.05	1.05	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	167.19	1.32	0.88	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	113.42	0.84	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	82.69	0.21	0.00	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	87.88	0.33	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	157.45	0.82	0.54	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	222.42	2.14	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	163.18	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	115.15	0.74	0.74	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	107.01	0.87	0.65	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	124.83	0.84	0.42	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	124.88	0.00	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	140.37	1.30	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	155.15	2.18	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	159.84	0.00	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	162.48	0.00	0.92	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	136.79	2.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	170.59	0.28	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	198.52	1.23	0.49	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	164.78	0.00	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	166.88	2.51	1.07	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	162.04	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	166.64	0.33	0.65	0.65
CD8+ T Cells, donor2	11307-117C2	133.65	0.38	0.75	0.00
CD8+ T Cells, donor3	11383-118B6	159.83	1.51	1.26	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	49.09	1.61	0.46	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	45.53	0.48	0.72	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	47.60	1.09	0.55	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	33.02	0.30	0.60	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	46.08	0.48	0.24	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	40.47	0.68	0.45	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	49.54	0.87	0.43	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	52.38	0.26	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	46.20	0.70	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	49.51	0.30	0.91	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	61.59	0.29	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	53.55	1.07	0.00	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	46.84	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	49.19	1.37	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	43.26	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	41.78	1.08	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	44.88	0.29	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	36.53	0.71	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	48.49	0.32	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	49.52	1.23	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	43.92	0.32	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	61.58	1.53	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	61.87	0.79	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	54.46	1.51	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	76.28	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	104.21	0.70	2.80	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	98.17	2.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	98.70	0.00	3.66	0.00
Cardiac Myocyte, donor2	11605-120I3	50.89	0.00	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	68.51	0.95	0.63	0.32
Chondrocyte - de diff, donor1	11261-116G1	70.03	1.04	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	80.32	1.78	0.36	1.07
Chondrocyte - de diff, donor3	11410-118E6	56.21	1.14	0.34	0.57
Chondrocyte - re diff, donor2	11339-117F7	101.16	1.79	2.69	0.90
Chondrocyte - re diff, donor3	11411-118E7	96.25	3.64	0.00	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	81.59	3.56	0.34	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	61.35	1.92	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	79.65	3.54	0.18	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	111.97	4.31	0.64	1.01
Corneal Epithelial Cells, donor1	11526-119I5	50.72	1.54	0.22	1.10
Corneal Epithelial Cells, donor2	11606-120I4	48.92	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	48.31	0.77	0.26	1.53
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	99.72	0.83	0.00	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	101.56	0.32	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	79.37	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	69.01	0.43	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	119.57	1.02	0.68	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	109.68	0.65	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	138.41	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	131.25	0.83	0.83	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	93.88	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	98.70	0.57	0.85	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	110.09	0.39	1.18	0.79
Endothelial Cells - Artery, donor1	11264-116G4	71.55	0.87	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	64.23	0.71	0.71	0.71
Endothelial Cells - Artery, donor3	11413-118E9	116.23	1.75	0.70	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	86.44	0.66	1.11	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	87.93	1.52	1.83	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	82.60	0.28	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	94.79	0.30	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	74.46	0.52	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	76.85	0.71	1.28	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	117.64	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	87.53	0.00	1.57	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	119.77	1.12	1.12	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	86.47	0.43	0.43	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	88.79	1.47	0.49	0.61
Endothelial Cells - Vein, donor1	11267-116G7	100.10	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	133.41	2.10	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	93.26	0.63	0.16	0.31
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	526.43	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	363.82	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	49.35	0.73	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	47.84	0.00	4.16	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	71.43	2.87	0.82	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	26.28	1.75	0.22	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	44.74	0.87	0.54	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	72.53	1.70	0.36	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	140.97	5.60	2.73	2.05
Fibroblast - Aortic Adventitial, donor2	11326-117E3	45.67	1.27	0.74	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	102.76	1.58	1.58	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	56.14	1.99	1.66	0.66
Fibroblast - Cardiac, donor1	11268-116G8	66.68	0.91	0.00	0.91
Fibroblast - Cardiac, donor2	11345-117G4	110.66	2.27	0.76	1.52
Fibroblast - Cardiac, donor3	11417-118F4	61.51	1.26	0.16	0.63
Fibroblast - Cardiac, donor4	11452-119A3	75.47	1.52	0.61	0.91
Fibroblast - Cardiac, donor5	11456-119A7	70.05	0.63	0.13	0.51
Fibroblast - Cardiac, donor6	11460-119B2	65.03	0.91	0.30	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	110.54	0.67	1.74	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	85.42	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	61.52	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	66.65	0.69	0.46	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	88.19	2.37	1.36	0.51
Fibroblast - Dermal, donor1	11269-116G9	39.21	1.88	0.23	0.94
Fibroblast - Dermal, donor2	11346-117G5	87.73	2.36	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	51.62	1.45	0.24	0.36
Fibroblast - Dermal, donor4	11450-119A1	48.04	0.23	0.23	0.11
Fibroblast - Dermal, donor5	11454-119A5	51.46	0.00	0.70	0.17
Fibroblast - Dermal, donor6	11458-119A9	60.58	0.65	0.65	0.65
Fibroblast - Gingival, donor1	11237-116D4	66.22	2.29	0.42	1.25
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	84.10	2.10	0.26	1.05
Fibroblast - Gingival, donor2	11318-117D4	60.49	1.32	0.26	0.53
Fibroblast - Gingival, donor3	11394-118C8	54.24	1.35	0.10	0.68
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	57.14	4.16	3.12	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	56.91	1.76	0.35	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	82.00	2.65	0.16	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	67.21	0.68	0.68	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	36.35	2.12	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	99.45	2.19	0.58	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	85.77	2.18	0.68	0.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	76.24	1.21	0.55	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	81.44	1.47	0.15	0.59
Fibroblast - Lung, donor1	11270-116H1	72.05	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	61.18	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	66.69	2.32	0.21	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	114.12	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	55.95	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	48.70	0.84	0.84	0.56
Fibroblast - Mammary, donor1	11540-120B1	105.96	2.03	2.03	0.81
Fibroblast - Mammary, donor2	11620-122A9	43.94	7.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	95.30	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	75.84	1.75	0.00	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	67.80	0.76	0.61	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	61.50	1.84	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	67.93	1.14	0.76	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	63.99	1.62	0.27	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	60.19	1.39	0.23	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	74.50	2.43	0.55	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	93.26	1.83	1.22	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	87.53	2.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	62.07	1.58	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	137.33	1.19	1.19	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	60.92	1.24	0.18	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	65.63	2.37	0.39	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	124.55	0.60	1.20	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	75.67	0.22	0.97	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	148.30	0.76	0.51	1.01
Fibroblast - skin normal, donor1	11553-120C5	69.41	1.15	0.98	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	140.56	5.61	1.20	0.80
Fibroblast - skin normal, donor2	11561-120D4	79.67	0.40	0.70	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	175.00	0.60	2.12	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	74.98	2.07	0.50	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	73.00	0.00	0.68	1.20
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	108.05	0.33	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	75.10	0.85	0.85	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	79.11	1.35	0.17	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	36.70	1.73	0.63	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	155.12	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	87.15	1.74	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	81.48	1.39	0.35	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	80.15	3.38	0.78	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	75.89	1.02	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	113.30	1.53	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	100.82	2.55	1.91	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	135.79	2.57	0.00	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	111.41	3.86	0.83	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	93.84	2.05	1.60	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	106.00	3.57	0.79	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	104.15	2.38	0.79	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	81.86	2.61	1.63	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	122.94	1.77	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	101.33	1.55	0.42	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	77.95	0.99	0.49	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	80.32	2.42	0.54	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	77.31	0.99	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	79.73	1.38	0.14	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	62.41	1.63	1.02	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	68.68	0.91	0.23	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	77.48	1.25	0.12	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	73.22	1.53	0.87	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	67.37	2.07	0.00	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	68.51	0.79	0.00	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	61.44	1.34	0.00	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	63.51	1.21	0.20	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	73.29	1.19	0.68	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	80.25	1.86	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	79.50	1.87	0.31	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	65.58	1.54	0.68	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	73.36	0.89	0.44	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	84.94	1.58	0.50	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	73.71	0.61	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	69.52	1.24	0.21	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	76.32	0.92	0.46	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	69.04	1.17	0.00	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	66.13	0.22	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	83.63	0.49	0.12	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	60.95	0.65	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	69.60	0.96	0.32	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	71.63	0.76	0.09	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	62.80	0.16	0.63	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	54.74	1.52	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	69.83	1.05	0.21	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	74.87	0.88	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	62.00	1.68	0.84	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	63.61	1.67	0.28	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	56.42	0.27	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	53.55	1.07	0.31	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	63.60	0.91	0.39	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	69.94	0.54	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	76.69	1.47	1.29	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	67.77	1.10	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	73.39	0.99	0.99	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	65.56	1.19	0.79	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	67.79	1.82	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	77.26	1.02	1.78	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	142.13	0.40	0.40	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	99.84	1.54	0.31	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	135.43	1.64	0.20	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	105.46	2.19	2.19	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	100.31	1.13	1.13	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	121.76	0.92	0.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	96.52	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	77.75	1.55	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	86.64	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	83.46	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	75.84	1.63	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	70.42	0.82	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	103.30	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	70.19	1.12	0.28	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	75.50	1.96	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	87.24	1.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	90.01	1.91	0.95	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	83.90	1.02	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	98.14	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	99.08	1.72	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	75.18	0.59	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	81.32	1.69	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	89.05	0.41	0.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	84.92	1.15	0.23	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	105.37	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	83.42	0.38	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	96.49	1.30	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	80.26	1.34	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	88.23	0.39	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	105.10	1.03	0.34	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	96.91	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	92.48	0.47	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	92.94	1.21	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	117.00	0.51	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	88.54	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	104.59	0.00	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	144.01	2.36	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	105.60	0.00	0.00	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	107.53	1.32	2.19	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	88.16	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	90.73	1.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	72.79	1.94	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	90.16	1.14	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	67.36	1.25	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	110.20	2.25	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	50.43	1.27	0.63	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	36.76	0.84	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	42.94	1.39	0.35	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	45.58	0.68	0.17	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	37.77	1.37	0.46	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	43.94	1.09	0.33	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	42.98	1.07	0.43	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	44.35	1.94	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	50.06	0.50	0.00	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	39.11	1.54	0.69	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	40.69	1.28	0.00	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	81.70	0.00	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	79.63	0.87	1.30	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	89.89	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	98.06	2.47	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	97.35	1.45	2.18	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	52.98	0.00	0.17	0.70
Hepatocyte, donor1	11523-119I2	72.64	2.42	1.21	0.00
Hepatocyte, donor2	11603-120I1	82.95	1.08	2.15	0.00
Hepatocyte, donor3	11684-122I1	88.96	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	306.76	3.92	1.96	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	192.96	2.62	1.05	1.92
Iris Pigment Epithelial Cells, donor1	11530-119I9	56.12	1.78	0.27	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	146.46	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	146.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	162.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	142.59	2.77	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	112.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	178.02	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	156.34	2.56	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	191.97	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	167.31	4.87	0.00	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	100.04	5.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	134.33	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	198.52	1.32	1.32	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	96.45	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	120.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	139.83	4.41	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	136.10	0.00	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	146.35	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	190.58	2.58	0.00	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	222.17	1.61	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	155.33	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	225.72	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	169.18	4.20	0.84	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	143.72	0.00	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	186.45	2.41	1.61	3.21
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	98.79	1.85	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	180.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	113.29	1.89	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	91.61	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	235.88	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	207.69	0.00	1.08	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	155.00	5.08	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	246.46	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	179.83	1.91	1.91	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	151.28	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	173.85	15.80	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	164.95	3.57	1.43	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	185.83	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	145.94	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	107.72	2.47	1.85	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	147.51	5.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	113.15	0.00	0.00	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	142.55	2.78	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	150.49	4.43	0.00	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	103.74	3.24	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	160.44	5.23	1.74	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	155.24	0.00	0.00	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	149.84	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	156.82	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	131.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	156.73	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	124.26	0.92	0.92	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	124.04	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	198.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	146.97	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	50.67	2.45	0.24	0.65
Keratinocyte - epidermal, donor2	11349-117G8	60.32	1.17	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	51.02	0.76	0.09	0.28
Keratinocyte - oral, donor1	11251-116E9	65.05	1.48	0.34	0.34
Keratocytes, donor1	11527-119I6	69.11	2.75	0.69	0.69
Keratocytes, donor2	11607-120I5	78.51	3.52	1.17	0.00
Keratocytes, donor3	11688-122I5	35.17	0.40	0.00	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	123.08	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	48.54	1.08	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	67.47	1.85	0.46	0.69
Lens Epithelial Cells, donor3	11690-122I7	91.83	3.13	1.92	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	81.34	0.83	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	56.65	0.84	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	85.95	0.31	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	60.22	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	66.82	1.26	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	69.97	0.97	0.22	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	54.99	0.00	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	57.39	0.25	0.76	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	72.35	0.70	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	45.88	0.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	48.66	0.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	61.84	0.74	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	55.75	1.05	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	61.78	0.48	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	69.09	0.69	0.41	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	48.97	0.31	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	60.48	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	84.72	0.18	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	45.09	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	61.80	0.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	84.64	0.50	1.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	51.89	1.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	46.59	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	68.73	0.30	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	44.58	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	50.46	0.21	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	77.59	0.30	0.60	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	56.41	0.69	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	44.97	0.75	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	66.37	0.42	0.64	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	53.30	1.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	46.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	62.07	0.37	0.00	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	71.45	0.74	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	41.51	0.25	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	58.16	0.69	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	57.25	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	50.82	1.22	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	62.70	0.56	0.84	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	59.38	1.07	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	46.05	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	72.36	0.78	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	61.95	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	39.85	0.33	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	70.16	0.00	0.24	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	74.37	0.74	0.99	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	44.57	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	59.37	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	63.45	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	44.49	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	35.63	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	55.01	1.69	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	33.76	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	45.76	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	40.71	0.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	38.06	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	54.96	1.13	0.23	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	41.30	0.00	0.58	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	38.72	0.90	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	65.85	1.08	0.41	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	44.68	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	43.40	0.35	0.35	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	30.65	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	51.45	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	47.49	0.80	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	43.46	0.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	44.18	1.84	1.23	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	53.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	37.07	0.42	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	43.16	0.56	0.56	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	42.24	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	47.32	0.58	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	43.34	0.60	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	39.28	1.11	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	49.13	0.35	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	50.52	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	52.96	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	52.96	0.77	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	57.18	1.13	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	39.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	50.16	0.45	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	38.06	2.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	41.83	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	40.88	0.37	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	40.49	0.86	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	51.38	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	47.31	1.00	0.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	46.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	49.77	1.42	0.00	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	50.87	1.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	53.67	0.54	1.61	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	39.05	0.67	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	47.41	1.11	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	66.29	1.16	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	48.66	2.12	2.12	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	63.62	0.40	0.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	55.24	0.73	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	65.92	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	49.33	0.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	49.87	2.82	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	53.80	0.50	1.01	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	64.44	0.45	0.90	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	56.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	58.34	0.45	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	58.65	0.00	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	57.40	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	59.68	0.00	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	49.01	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	48.64	0.00	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	46.81	0.44	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	50.14	0.77	1.16	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	41.52	1.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	43.74	1.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	52.08	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	38.28	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	48.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	52.82	0.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	53.19	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	48.37	0.00	1.21	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	50.39	0.32	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	60.24	1.60	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	48.85	0.57	1.72	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	46.28	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	38.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	58.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	60.74	0.42	0.83	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	54.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	52.19	0.00	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	51.57	0.00	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	50.85	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	67.90	0.00	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	54.15	0.81	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	53.23	0.92	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	64.02	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	58.13	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	55.98	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	38.85	0.00	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	46.77	0.45	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	72.79	0.52	0.78	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	43.77	0.00	0.66	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	76.91	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	90.25	0.00	0.68	0.91
Macrophage - monocyte derived, donor2	11313-117C8	67.53	1.10	0.00	0.37
Macrophage - monocyte derived, donor3	11389-118C3	73.67	0.52	0.39	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	56.29	3.19	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	71.62	1.43	0.16	0.48
Mallassez-derived cells, donor3	11930-125I4	70.19	1.25	0.56	0.42
Mammary Epithelial Cell, donor1	11273-116H4	61.28	1.49	0.40	0.60
Mammary Epithelial Cell, donor2	11350-117G9	57.04	2.03	0.58	0.87
Mammary Epithelial Cell, donor3	11422-118F9	73.83	1.50	0.50	0.50
Mast cell - stimulated, donor1	11487-119E2	130.16	1.36	0.68	0.00
Mast cell, donor1	11563-120D6	119.71	1.41	0.76	0.11
Mast cell, donor2	11565-120D8	178.01	0.89	1.19	0.30
Mast cell, donor3	11566-120D9	197.43	0.45	0.00	0.45
Mast cell, donor4	11567-120E1	153.36	0.71	0.71	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	157.14	0.89	1.11	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	145.34	1.17	0.58	1.75
Mast cell, expanded, donor5	11939-126A4	157.74	0.80	0.57	0.57
Mast cell, expanded, donor8	11941-126A6	194.65	1.34	0.50	0.33
Melanocyte - dark, donor1	11502-119F8	89.65	0.99	1.09	0.40
Melanocyte - dark, donor2	11582-120F7	64.03	1.04	0.35	1.04
Melanocyte - dark, donor3	11663-122F7	65.85	1.09	0.43	0.14
Melanocyte - light, donor1	11274-116H5	68.88	1.41	0.24	0.00
Melanocyte - light, donor2	11351-117H1	83.94	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	58.10	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	61.23	0.62	0.42	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	79.07	1.08	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	60.54	0.54	0.54	0.27
Meningeal Cells, donor1	11493-119E8	99.74	0.62	1.24	0.99
Meningeal Cells, donor2	11573-120E7	80.99	0.44	0.88	0.88
Meningeal Cells, donor3	11654-122E7	67.81	1.87	0.65	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	78.99	2.00	1.71	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	74.37	3.02	0.81	1.21
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	40.74	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	64.10	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	43.77	2.15	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	59.93	1.48	0.00	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	60.32	1.51	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	86.80	2.20	0.22	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	86.21	0.73	0.73	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	73.86	2.05	0.41	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	75.07	0.69	1.11	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	69.51	0.37	0.00	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	69.47	1.18	0.53	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	66.47	1.48	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	49.05	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	87.09	1.28	0.00	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	84.36	2.13	0.71	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	65.67	0.94	0.31	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	51.52	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	77.70	3.71	1.33	1.06
Mesothelial Cells, donor2	12156-128G5	66.56	4.50	2.00	0.00
Mesothelial Cells, donor3	11402-118D7	61.79	1.52	1.23	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	155.29	2.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	79.55	0.49	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	77.15	2.06	0.00	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	79.51	6.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	61.68	0.00	0.31	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	62.23	0.41	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	81.06	4.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	57.81	1.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	81.92	0.93	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	175.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	53.45	0.20	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	71.67	2.38	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	85.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	43.36	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	61.93	1.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	81.59	2.63	3.95	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	49.24	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	55.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	49.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	78.80	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	49.93	0.50	0.75	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	64.65	0.71	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	59.71	0.55	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	50.88	1.38	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	58.89	0.42	0.63	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	48.10	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	45.70	0.86	0.43	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	63.80	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	113.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	47.53	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	86.18	2.53	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	97.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	58.98	0.82	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	80.87	0.29	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	85.05	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	50.94	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	95.25	0.80	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	72.67	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	82.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	215.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	83.58	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	88.90	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	134.65	2.21	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	116.55	0.64	0.00	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	93.71	1.49	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	116.91	0.70	0.70	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	183.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	109.40	1.71	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	129.53	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	135.65	0.36	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	108.01	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	123.44	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	131.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	98.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	123.55	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	173.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	108.06	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	155.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	108.20	0.41	0.00	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	117.14	1.04	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	135.13	0.86	0.86	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	129.58	1.91	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	117.16	1.60	0.53	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	124.52	0.90	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	89.13	0.71	0.14	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	121.35	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	151.03	1.11	0.44	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	121.72	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	111.65	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	128.31	0.49	0.25	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	98.40	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	95.26	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	123.69	0.86	0.29	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	98.09	0.82	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	113.16	0.89	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	56.50	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	26.73	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	63.09	0.33	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	51.55	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	74.73	0.59	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	65.19	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	66.09	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	56.20	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	63.79	0.11	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	69.25	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	53.50	0.73	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	49.78	1.56	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	19.77	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	54.09	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	60.60	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	30.36	0.42	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	68.10	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	27.97	0.64	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	34.01	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	24.17	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	331.19	11.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	104.40	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	152.08	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	125.49	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	86.39	1.08	0.43	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	82.05	1.05	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	26.03	2.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	27.55	2.50	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	63.70	3.61	0.38	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	92.56	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	20.40	0.00	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	40.43	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	22.18	0.42	0.84	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	45.09	1.39	1.39	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	28.10	0.27	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	60.34	0.63	0.42	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	26.31	0.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	44.12	2.71	0.81	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	32.19	1.13	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	29.39	0.98	0.33	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	53.95	0.73	0.73	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	29.17	1.06	0.53	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	23.41	0.00	1.80	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	49.55	1.64	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	33.50	1.63	0.65	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	49.92	0.53	0.53	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	27.43	1.41	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	47.81	0.92	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	44.67	2.25	0.64	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	40.35	2.76	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	75.85	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	47.68	0.67	1.11	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	36.84	1.69	0.42	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	51.03	2.61	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	40.35	3.00	0.00	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	35.99	1.00	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	51.85	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	35.32	1.98	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	30.65	0.93	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	54.86	2.27	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	27.05	0.33	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	34.86	0.87	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	56.08	0.90	0.00	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	26.46	3.53	0.00	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	22.60	2.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	34.72	1.49	1.49	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	32.92	0.38	0.00	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	87.41	1.21	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	52.38	1.55	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	22.36	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	86.86	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	35.97	1.83	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	39.66	0.63	0.94	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	34.50	0.30	0.91	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	41.14	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	68.02	2.27	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	55.64	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	60.62	3.35	0.99	1.12
Myoblast, donor2	11322-117D8	67.32	2.88	0.58	0.96
Myoblast, donor3	11398-118D3	64.41	2.35	1.18	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	189.13	0.88	0.00	0.58
Natural Killer Cells, donor1	11230-116C6	151.91	0.62	0.31	0.62
Natural Killer Cells, donor2	11311-117C6	133.29	0.90	0.30	0.60
Natural Killer Cells, donor3	11387-118C1	133.81	0.37	0.18	0.18
Neural stem cells, donor1	11275-116H6	82.75	3.99	0.36	0.73
Neural stem cells, donor2	11352-117H2	88.58	3.85	1.93	1.93
Neurons, donor1	11494-119E9	81.93	2.28	4.55	2.28
Neurons, donor2	11574-120E8	108.98	6.60	0.66	2.20
Neurons, donor3	11655-122E8	102.77	6.58	0.82	0.82
Neutrophils, donor1	11233-116C9	231.07	0.00	0.93	0.93
Neutrophils, donor2	11314-117C9	156.54	2.90	2.90	0.00
Neutrophils, donor3	11390-118C4	262.05	1.22	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	86.44	1.90	0.47	0.95
Nucleus Pulposus Cell, donor2	11409-118E5	73.91	0.98	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	54.75	0.20	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	63.87	1.10	0.55	0.69
Olfactory epithelial cells, donor2	11934-125I8	68.32	1.16	0.00	0.29
Olfactory epithelial cells, donor3	11935-125I9	57.09	1.02	0.68	0.11
Olfactory epithelial cells, donor4	11936-126A1	77.33	2.14	0.39	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	95.69	1.81	0.00	1.20
Osteoblast - differentiated, donor1	11276-116H7	72.53	2.13	1.28	1.06
Osteoblast - differentiated, donor2	11353-117H3	49.15	1.14	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	42.83	1.86	0.00	0.00
Osteoblast, donor1	11277-116H8	154.59	3.91	1.56	1.95
Osteoblast, donor2	11354-117H4	93.41	0.70	0.70	0.00
Osteoblast, donor3	11426-118G4	103.79	4.09	0.89	1.07
Pancreatic stromal cells, donor1	11249-116E7	57.95	2.36	1.10	0.17
Pericytes, donor1	11491-119E6	80.33	1.00	0.67	0.45
Pericytes, donor2	11571-120E5	81.27	1.13	0.68	0.23
Pericytes, donor3	11652-122E5	87.28	2.24	0.00	0.81
Perineurial Cells, donor1	11499-119F5	73.80	1.92	0.34	0.79
Perineurial Cells, donor2	11579-120F4	78.39	1.75	0.83	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	158.09	1.27	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	96.72	0.73	0.49	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	110.52	0.39	0.52	0.13
Placental Epithelial Cells, donor1	11278-116H9	72.95	0.48	0.96	0.24
Placental Epithelial Cells, donor2	11355-117H5	58.77	2.22	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	62.24	1.37	0.59	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	33.23	0.32	0.32	1.27
Preadipocyte - breast, donor1	11467-119B9	63.40	1.13	0.94	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	130.27	3.26	1.83	1.17
Preadipocyte - breast, donor2	11328-117E5	57.86	1.58	1.13	0.45
Preadipocyte - omental, donor1	11468-119C1	73.31	2.02	0.96	0.21
Preadipocyte - omental, donor2	11329-117E6	72.02	2.62	1.31	0.00
Preadipocyte - omental, donor3	11403-118D8	62.89	1.86	0.72	1.00
Preadipocyte - perirenal, donor1	11469-119C2	51.18	0.00	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	148.03	6.45	2.76	1.84
Preadipocyte - subcutaneous, donor2	11356-117H6	81.28	2.66	0.35	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	68.45	2.04	0.51	1.19
Preadipocyte - visceral, donor1	11280-116I2	82.53	3.82	1.12	1.12
Preadipocyte - visceral, donor2	11357-117H7	67.65	0.92	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	56.53	0.73	1.36	0.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	157.49	2.56	0.60	1.21
Prostate Epithelial Cells, donor2	11331-117E8	41.30	1.35	0.68	0.14
Prostate Epithelial Cells, donor3	11404-118D9	19.11	0.80	0.18	0.49
Prostate Stromal Cells, donor1	11254-116F3	67.20	1.94	1.03	0.80
Prostate Stromal Cells, donor2	11332-117E9	62.75	1.97	0.36	0.72
Prostate Stromal Cells, donor3	11405-118E1	55.37	2.09	0.52	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	91.61	0.73	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	72.29	1.80	0.55	0.28
Renal Epithelial Cells, donor1	11517-119H5	60.87	2.03	0.00	1.01
Renal Epithelial Cells, donor2	11597-120H4	89.63	1.42	0.71	1.42
Renal Epithelial Cells, donor3	11678-122H4	83.10	2.33	0.32	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	83.74	0.00	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	88.41	0.27	0.54	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	84.81	0.89	0.22	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	36.60	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	110.26	3.30	0.44	0.44
Renal Mesangial Cells, donor2	11598-120H5	98.44	1.25	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	71.29	1.11	0.28	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	101.73	1.34	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	60.30	0.84	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	96.62	2.89	0.39	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	72.86	2.33	0.52	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	94.65	1.42	0.85	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	63.81	0.00	2.06	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	67.75	1.51	1.00	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	90.20	1.60	1.07	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	65.22	2.68	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	31.37	1.10	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	35.96	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	54.87	0.26	0.52	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	41.61	1.29	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	64.36	2.34	0.33	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	50.61	0.25	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	41.96	1.05	0.47	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	59.86	0.69	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	44.22	0.00	0.14	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	40.54	0.76	0.15	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	68.63	1.79	0.72	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	46.05	0.29	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	38.96	0.43	0.32	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	57.09	0.44	0.66	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	36.90	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	41.46	0.84	0.47	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	65.96	1.88	0.94	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	40.34	0.27	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	43.61	1.07	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	52.32	1.15	0.38	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	42.93	0.43	0.53	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	35.88	1.68	0.00	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	51.61	1.71	0.68	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	43.03	0.55	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	43.66	1.10	0.37	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	53.46	1.07	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	40.81	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	48.21	0.99	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	58.70	0.94	0.23	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	48.52	0.00	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	42.25	0.22	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	55.98	0.42	1.04	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	49.26	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	51.77	1.02	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	55.52	1.16	0.39	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	45.22	0.52	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	40.19	0.96	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	56.15	2.30	0.49	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	41.76	0.17	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	42.76	1.33	1.18	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	42.12	1.07	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	48.25	0.14	0.55	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	48.33	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	52.80	1.01	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	42.00	0.66	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	41.22	0.70	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	50.47	1.81	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	42.22	0.73	0.24	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	124.30	3.35	0.58	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	47.46	0.61	0.61	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	34.96	0.00	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	49.99	0.23	0.45	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	68.89	1.20	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	60.45	0.12	0.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	63.82	0.85	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	71.52	1.80	0.00	0.00
Schwann Cells, donor1	11498-119F4	73.16	0.75	1.13	0.19
Schwann Cells, donor2	11578-120F3	40.83	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	56.96	1.53	1.10	0.00
Sebocyte, donor1	11220-116B5	65.18	0.55	1.10	0.00
Sebocyte, donor2	11301-117B5	39.06	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	42.05	1.03	0.21	0.62
Sertoli Cells, donor1	11255-116F4	84.49	0.00	3.31	1.66
Sertoli Cells, donor2	11333-117F1	59.31	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	64.75	1.85	0.79	0.70
Skeletal Muscle Cells, donor2	11358-117H8	44.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	113.70	4.18	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	64.88	0.47	0.31	0.63
Skeletal Muscle Cells, donor5	11455-119A6	61.54	1.34	0.45	0.15
Skeletal Muscle Cells, donor6	11459-119B1	60.33	0.46	0.15	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	95.51	3.02	0.63	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	72.91	1.28	0.29	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	75.60	2.48	0.30	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	79.70	2.11	0.59	1.26
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	86.13	0.72	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	77.74	0.96	0.83	0.14
Skin - palm, donor1	10286-104F7	171.91	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	28.69	0.58	0.14	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	224.92	3.27	2.45	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	22.59	0.52	0.13	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	50.18	1.95	0.42	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	41.78	0.56	0.14	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	230.48	5.07	1.69	2.11
Small Airway Epithelial Cells, donor3	11406-118E2	32.45	1.12	0.30	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	45.67	0.62	0.00	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	86.71	0.89	0.67	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	99.34	1.18	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	180.77	3.98	1.33	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	142.15	5.12	2.76	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	106.61	6.95	1.55	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	58.04	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	118.31	4.26	1.33	1.33
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	72.04	1.99	1.33	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	98.71	1.15	1.02	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	79.77	1.95	1.95	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	82.69	3.54	0.89	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	66.06	1.57	0.43	1.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	70.60	1.79	0.81	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	47.49	0.30	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	139.41	3.28	1.26	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	214.22	0.00	12.24	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	103.95	0.48	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	65.92	1.47	0.29	1.18
Smooth Muscle Cells - Colonic, donor2	11320-117D6	59.19	3.01	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	68.01	1.15	0.73	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	152.98	4.02	1.70	1.08
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	125.03	2.16	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	105.50	0.60	0.30	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	77.16	2.39	1.02	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	71.23	0.94	0.31	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	76.29	4.03	1.01	1.11
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	105.58	2.05	0.68	1.59
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	109.29	0.00	0.60	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	57.75	2.65	1.06	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	72.70	0.53	0.40	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	63.99	1.50	0.50	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	53.52	1.27	1.01	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	123.03	3.32	1.21	1.66
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	85.52	1.50	0.75	3.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	505.26	9.05	0.00	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	145.10	3.26	0.93	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	66.14	3.03	0.00	2.52
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	111.88	0.94	1.57	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	65.49	2.06	0.29	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	68.14	2.00	0.67	0.83
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	45.31	1.87	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	125.64	5.61	2.30	1.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	100.71	4.33	0.76	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	94.96	0.38	1.88	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	64.70	1.40	0.56	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	69.29	1.68	0.50	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	21.43	0.95	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	101.78	2.94	0.24	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	66.73	1.33	0.22	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	43.01	2.34	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	49.17	1.36	0.58	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	49.98	1.32	0.79	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	42.40	1.49	0.00	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	58.21	1.44	1.08	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	59.62	1.42	0.00	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	55.93	1.18	1.58	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	44.19	0.51	0.25	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	61.10	0.80	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	51.83	1.67	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	55.46	1.83	0.92	0.00
Synoviocyte, donor1	11291-117A4	87.70	2.02	0.17	0.34
Synoviocyte, donor2	11368-117I9	59.17	1.17	0.84	0.34
Synoviocyte, donor3	11440-118H9	44.68	0.45	0.45	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	89.33	1.79	0.36	1.43
Trabecular Meshwork Cells, donor2	11612-122A1	43.60	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	58.12	0.23	0.23	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	67.17	1.51	0.29	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	49.48	1.55	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	61.27	0.00	0.00	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	91.41	1.35	0.98	0.62
Urethra, donor2	10319-105A4	100.71	3.60	0.00	0.00
Urothelial Cells, donor1	11520-119H8	60.57	1.86	0.53	1.33
Urothelial Cells, donor2	11600-120H7	52.87	1.20	0.40	0.80
Urothelial Cells, donor3	11681-122H7	56.16	0.69	0.00	0.00
Urothelial cells, donor0	11216-116B1	79.57	2.67	0.45	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	166.39	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	190.14	1.43	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	111.58	1.37	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	177.68	1.38	0.00	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	151.07	1.16	1.16	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	184.30	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	149.60	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	122.33	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	60.82	1.48	0.49	0.86
Wilms' tumor cell line:HFWT	10597-108E3	59.84	0.88	0.00	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	47.76	0.28	0.28	0.00
achilles tendon, donor2	10292-104G4	150.86	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	67.05	0.25	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	95.89	0.00	0.46	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	195.27	0.83	0.24	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	107.21	1.36	0.82	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	67.74	0.28	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	100.88	0.00	0.00	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	95.82	0.00	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	108.84	0.44	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	82.90	1.23	0.41	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	118.04	0.39	0.78	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	74.52	0.74	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	175.52	3.90	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	94.35	0.23	0.23	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	96.05	0.78	0.26	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	76.28	0.88	0.00	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	114.80	0.93	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	72.79	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	52.18	0.00	0.61	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	69.13	0.85	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	72.79	0.00	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	71.97	1.20	0.24	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	46.11	0.45	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	63.04	0.33	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	124.50	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	72.70	1.13	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	100.75	0.00	0.87	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	93.72	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	68.77	0.71	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	89.50	1.40	0.47	0.62
adipose, donor1	10184-103D4	139.57	5.28	1.76	0.00
adipose, donor2	10185-103D5	83.13	2.43	1.22	1.62
adipose, donor3	10186-103D6	102.11	1.63	1.09	0.27
adipose, donor4	10187-103D7	218.42	0.87	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	50.82	2.37	1.10	0.79
adrenal gland, adult, pool1	10081-102A9	98.22	0.00	3.64	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	74.97	0.53	0.13	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	75.03	2.86	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	57.03	1.62	0.23	0.46
amniotic membrane cells, donor2	12236-129G4	93.99	2.70	0.34	1.35
amniotic membrane cells, donor3	12237-129G5	51.85	0.00	0.59	0.59
amygdala - adult, donor10196	10167-103B5	80.63	2.37	2.37	2.37
amygdala, adult, donor10252	10151-102I7	95.91	3.04	0.61	1.42
amygdala, newborn, donor10223	10360-105E9	66.17	3.23	1.61	2.58
anaplastic carcinoma cell line:8305C	10428-106D5	126.31	1.91	0.51	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	81.41	1.32	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	96.20	3.67	1.00	1.00
aorta, adult, pool1	10052-101G7	71.59	0.98	0.20	0.59
appendix, adult	10189-103D9	110.23	1.16	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	125.19	2.41	0.34	1.38
artery, adult	10190-103E1	78.80	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	84.75	0.43	0.43	0.14
b cell line:RPMI1788	10427-106D4	75.09	1.04	0.15	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	87.12	2.77	1.11	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	81.57	1.29	0.30	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	85.70	0.84	1.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	77.17	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	66.60	1.74	0.43	0.33
blood, adult, pool1	10053-101G8	37.65	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	123.31	2.57	0.00	0.00
bone marrow, adult	10192-103E3	66.13	1.35	0.00	0.00
brain, adult, donor1	10084-102B3	91.23	4.10	0.00	2.05
brain, adult, pool1	10012-101C3	107.02	4.57	1.22	1.56
brain, fetal, pool1	10085-102B4	130.90	5.34	5.34	2.67
breast carcinoma cell line:MCF7	10482-107A5	57.48	0.66	0.66	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	122.33	4.74	3.00	1.12
breast, adult, donor1	10080-102A8	49.25	0.63	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	64.66	0.38	0.38	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	80.71	0.93	0.31	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	84.72	1.38	0.69	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	59.80	1.69	0.00	0.48
carcinoid cell line:NCI-H1770	10703-109H1	79.93	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	81.05	0.98	0.55	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	38.34	0.95	0.32	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	74.53	1.86	1.33	2.40
caudate nucleus - adult, donor10196	10177-103C6	88.65	2.30	1.15	2.30
caudate nucleus, adult, donor10252	10164-103B2	93.54	4.85	0.84	2.01
caudate nucleus, adult, donor10258	10379-105H1	81.76	4.58	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	78.37	2.56	2.20	1.83
cerebellum - adult, donor10196	10173-103C2	134.01	2.91	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	150.95	5.76	0.64	1.71
cerebellum, adult, pool1	10083-102B2	94.86	6.90	1.72	2.07
cerebellum, newborn, donor10223	10357-105E6	179.34	6.64	1.66	4.15
cerebral meninges, adult	10188-103D8	86.74	4.03	0.76	1.01
cerebrospinal fluid, donor2	10294-104G6	73.09	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	64.70	2.30	2.01	1.01
cervical cancer cell line:ME-180	10553-107I4	71.26	0.83	0.33	0.50
cervix, adult, pool1	10013-101C4	94.07	3.36	0.42	0.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	183.23	5.29	2.09	2.09
chondrosarcoma cell line:SW 1353	10700-109G7	62.70	1.31	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	94.95	0.75	0.37	0.50
choriocarcinoma cell line:SCH	10785-110H2	63.33	0.74	0.37	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	43.17	0.24	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	53.00	0.28	0.57	0.28
chorionic membrane cells, donor2	12239-129G7	95.95	2.39	1.39	0.80
chorionic membrane cells, donor3	12240-129G8	70.88	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	48.47	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	70.88	1.92	0.38	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	83.84	0.84	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	55.73	1.80	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	56.84	0.73	0.24	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	62.10	1.02	0.00	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	134.86	3.24	1.18	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	77.15	1.30	1.30	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	92.58	0.69	0.69	0.46
clear cell carcinoma cell line:TEN	10636-108I6	97.51	1.39	0.69	1.04
colon carcinoma cell line:CACO-2	10513-107D9	209.95	1.83	0.55	0.73
colon carcinoma cell line:COLO-320	10420-106C6	180.54	1.90	0.38	1.14
colon, adult, donor1	10082-102B1	111.86	3.57	0.00	0.00
colon, adult, pool1	10014-101C5	103.05	1.18	0.35	0.35
colon, fetal, donor1	10070-101I7	54.38	0.62	0.62	1.24
common myeloid progenitor CMP, donor1	12130-128D6	1109.21	9.17	13.75	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	147.88	1.27	1.70	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	93.88	1.06	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	108.58	0.42	0.28	0.14
corpus callosum, adult, pool1	10042-101F6	251.31	4.09	0.77	1.44
cruciate ligament, donor2	10295-104G7	136.16	0.00	0.81	1.62
diaphragm, fetal, donor1	10069-101I6	64.21	0.00	0.00	0.80
diencephalon, adult	10193-103E4	73.44	1.44	0.24	1.92
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	48.91	0.23	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	116.94	2.56	0.00	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	42.37	2.89	0.00	0.48
ductus deferens, adult	10196-103E7	109.14	4.49	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	86.41	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	102.26	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	136.27	1.65	0.74	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	141.24	2.00	0.44	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	91.56	1.29	0.57	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	96.81	1.23	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	68.41	0.91	0.61	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	80.27	0.93	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	102.45	0.00	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	95.53	0.67	0.67	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	53.83	1.09	1.09	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	42.13	1.45	0.32	0.00
epidermoid carcinoma cell line:A431	10426-106D3	73.14	1.11	0.56	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	96.79	2.53	0.88	0.77
epididymis, adult	10197-103E8	93.98	2.93	0.63	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	65.46	2.66	1.06	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	41.29	1.18	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	88.20	1.97	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	63.87	1.48	0.39	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	86.04	1.23	0.56	0.56
esophagus, adult, pool1	10015-101C6	57.76	0.96	0.21	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	70.76	3.63	1.38	1.50
eye - muscle inferior rectus, donor1	10272-104E2	147.29	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	98.90	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	101.20	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	99.75	1.15	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	97.65	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	51.86	0.25	0.51	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	56.42	0.38	0.00	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	77.16	1.42	0.47	0.47
frontal lobe, adult, pool1	10040-101F4	127.60	4.32	2.16	1.60
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	107.79	3.30	0.30	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	98.93	0.82	0.27	0.73
gall bladder, adult	10198-103E9	85.71	0.97	0.48	0.24
gamma delta positive T cells, donor1	11937-126A2	173.40	0.00	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	144.91	1.87	1.49	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	66.32	1.06	1.06	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	117.60	0.77	0.58	0.97
gastric cancer cell line:AZ521	10549-107H9	86.40	2.13	2.30	1.48
gastric cancer cell line:GSS	10560-108A2	275.48	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	90.47	0.46	0.23	1.14
giant cell carcinoma cell line:LU65	10487-107B1	16.75	1.61	0.11	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	89.57	1.40	0.56	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	43.65	1.25	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	75.36	3.91	2.11	2.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	78.93	5.90	1.54	1.83
glioblastoma cell line:T98G	10485-107A8	97.35	1.99	1.32	1.55
glioma cell line:GI-1	10413-106B8	72.05	1.76	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	147.24	2.19	1.46	1.46
globus pallidus, adult, donor10252	10161-103A8	178.68	3.66	0.73	1.46
globus pallidus, adult, donor10258	10367-105F7	171.15	4.11	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	80.47	3.20	1.07	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	1037.59	2.45	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	83.63	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	62.08	1.28	1.60	0.32
hIPS +CCl2, biol_rep1	14383-156B9	140.49	0.46	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	108.83	0.46	0.91	0.91
hIPS +CCl2, biol_rep3	14385-156C2	144.28	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	66.12	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	131.00	0.69	1.37	0.00
hIPS, biol_rep3	14382-156B8	72.83	0.00	0.00	2.21
hairy cell leukemia cell line:Mo	10712-109I1	88.21	0.29	0.00	0.00
heart - mitral valve, adult	10205-103F7	71.75	0.90	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	67.72	0.26	0.26	0.52
heart - tricuspid valve, adult	10207-103F9	104.08	0.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	67.95	1.84	0.61	0.41
heart, adult, diseased, donor1	10051-101G6	74.09	0.43	0.85	0.43
heart, adult, pool1	10016-101C7	83.02	0.46	0.46	0.46
heart, fetal, pool1	10046-101G1	116.44	0.82	0.51	1.03
hepatic mesenchymal tumor cell line:LI90	10778-110G4	87.93	1.54	0.31	1.54
hepatoblastoma cell line:HuH-6	10633-108I3	130.81	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	182.54	2.54	0.44	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	186.19	2.43	0.85	1.21
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	187.76	1.41	0.51	1.01
hepatoma cell line:Li-7	10484-107A7	94.87	1.89	0.33	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	55.07	0.50	0.40	0.20
hippocampus - adult, donor10196	10169-103B7	93.69	5.68	0.00	1.89
hippocampus, adult, donor10252	10153-102I9	104.09	3.06	1.43	0.61
hippocampus, adult, donor10258	10374-105G5	92.62	0.50	0.50	1.49
hippocampus, newborn, donor10223	10363-105F3	71.55	6.70	1.06	3.52
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	149.53	3.66	0.00	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	86.59	0.39	0.39	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	108.67	2.03	0.76	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	93.60	1.69	1.69	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	87.53	1.29	0.77	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	100.60	4.18	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	96.93	3.21	1.17	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	79.06	1.94	1.08	2.15
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	88.00	2.92	1.67	2.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	82.17	2.13	0.47	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	69.11	2.09	0.80	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	86.18	3.37	2.69	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	74.02	0.78	0.31	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	69.76	0.49	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	114.33	0.00	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	95.46	1.91	1.91	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	77.18	2.62	0.87	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	109.45	1.50	1.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	86.85	3.77	0.94	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	87.31	2.73	0.91	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	98.98	3.45	2.19	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	64.50	2.12	0.33	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	62.71	2.90	0.58	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	71.14	2.69	1.79	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	81.84	0.92	0.37	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	81.02	0.86	0.29	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	126.98	2.04	1.22	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	86.26	0.70	0.35	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	77.92	1.27	1.27	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	94.42	2.42	0.61	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	76.53	1.03	1.55	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	89.00	1.33	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	82.60	4.10	1.03	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	69.79	1.02	1.02	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	78.75	1.51	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	69.23	3.36	2.35	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	84.29	0.97	0.24	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	99.38	1.34	0.45	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	91.22	2.44	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	86.49	1.83	0.61	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	253.75	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	128.74	2.98	1.65	2.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	73.34	1.09	1.09	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	105.67	5.43	0.36	1.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	67.62	1.78	2.49	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	54.90	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	89.79	2.71	0.54	0.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	71.12	1.89	2.69	1.08
immature langerhans cells, donor1	11904-125F5	106.54	0.48	0.48	0.00
immature langerhans cells, donor2	11905-125F6	117.24	2.38	0.00	0.79
insula, adult, pool1	10039-101F3	136.27	5.39	1.51	2.18
keratoacanthoma cell line:HKA-1	10791-110H8	47.80	0.33	0.33	0.33
kidney, adult, pool1	10017-101C8	76.40	2.10	0.70	0.30
kidney, fetal, pool1	10045-101F9	108.01	1.91	0.57	0.92
large cell lung carcinoma cell line:IA-LM	10509-107D5	170.85	2.70	0.99	1.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	67.46	0.55	0.28	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	52.48	0.37	0.55	0.37
left atrium, adult, donor1	10079-102A7	35.42	0.00	0.00	1.09
left ventricle, adult, donor1	10078-102A6	38.94	0.00	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	51.17	4.38	0.82	0.55
leiomyoma cell line:10964C	10569-108B2	48.86	2.87	0.36	1.08
leiomyoma cell line:15242A	10570-108B3	47.83	1.63	1.09	0.54
leiomyoma cell line:15425	10571-108B4	47.83	2.91	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	69.84	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	77.37	5.23	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	116.17	1.53	0.24	0.35
liposarcoma cell line:KMLS-1	10782-110G8	85.29	2.03	0.47	0.78
liposarcoma cell line:SW 872	10726-110A6	86.14	1.58	0.24	0.97
liver, adult, pool1	10018-101C9	72.44	2.27	0.81	0.81
liver, fetal, pool1	10086-102B5	59.26	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	114.33	3.35	1.17	2.19
locus coeruleus, adult, donor10252	10165-103B3	117.74	4.98	0.55	1.29
locus coeruleus, adult, donor10258	10375-105G6	72.51	3.10	0.56	1.13
locus coeruleus, newborn, donor10223	10362-105F2	66.88	3.79	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	72.66	1.38	0.42	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	73.08	2.76	0.69	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	82.12	0.53	0.00	0.00
lung, adult, pool1	10019-101D1	82.57	0.59	0.35	0.24
lung, fetal, donor1	10068-101I5	152.98	0.57	1.71	0.00
lung, right lower lobe, adult, donor1	10075-102A3	73.31	0.00	1.37	0.00
lymph node, adult, donor1	10077-102A5	61.06	0.47	0.47	1.42
lymphangiectasia cell line:DS-1	10727-110A7	54.58	0.44	0.00	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	60.22	0.30	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	83.25	2.55	0.00	0.00
mature adipocyte, donor1	12231-129F8	200.68	6.66	0.89	0.00
mature adipocyte, donor2	12232-129F9	144.44	3.32	0.62	0.42
mature adipocyte, donor3	12233-129G1	128.25	1.90	0.47	0.95
mature adipocyte, donor4	12234-129G2	152.14	1.58	0.79	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	139.86	5.72	0.95	1.67
medial frontal gyrus - adult, donor10196	10170-103B8	103.78	7.90	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	103.54	2.94	0.55	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	99.44	4.13	0.00	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	77.19	7.68	1.71	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	97.54	4.39	1.18	1.86
medial temporal gyrus, adult, donor10252	10156-103A3	116.51	4.46	0.42	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	75.12	5.78	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	72.86	4.31	1.44	1.44
medulla oblongata - adult, donor10196	10174-103C3	107.73	3.89	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	104.80	2.79	0.31	1.55
medulla oblongata, adult, pool1	10038-101F2	135.58	4.98	0.49	1.55
medulla oblongata, newborn, donor10223	10361-105F1	89.23	4.51	1.04	1.74
medulloblastoma cell line:D283 Med	10838-111E1	96.98	1.55	1.33	0.89
medulloblastoma cell line:ONS-76	10759-110E3	83.51	0.98	0.00	0.86
melanoma cell line:COLO 679	10514-107E1	88.12	1.58	0.29	0.14
melanoma cell line:G-361	10465-106H6	61.08	0.81	0.27	0.81
meningioma cell line:HKBMM	10691-109F7	55.54	1.09	0.54	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	76.66	3.52	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	82.69	1.30	1.04	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	87.46	0.31	0.92	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	54.53	0.36	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	69.57	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	53.66	0.28	0.56	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	67.78	0.39	0.00	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	80.51	3.47	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	57.15	0.86	0.51	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	68.55	0.69	0.12	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	68.18	1.33	0.53	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	82.78	0.95	0.41	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	82.51	0.57	1.14	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	51.71	1.65	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	75.00	1.11	1.25	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	81.34	1.40	0.35	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	65.13	0.20	0.61	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	67.58	2.16	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	57.52	0.31	0.31	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	61.33	0.91	0.68	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	88.11	0.84	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	82.79	1.20	0.45	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	66.96	0.70	0.35	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	71.79	0.37	0.74	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	74.11	2.29	0.29	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	54.73	1.26	0.00	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	48.41	0.91	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	55.76	1.28	1.02	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	58.63	0.00	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	57.00	2.46	0.31	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	47.54	0.94	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	61.94	1.69	0.68	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	63.66	1.57	0.39	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	56.07	1.85	0.00	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	59.41	0.58	1.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	60.46	1.56	0.22	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	59.85	3.36	0.96	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	54.27	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	59.08	1.68	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	61.00	1.23	0.82	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	61.00	1.72	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	49.22	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	74.38	0.97	0.97	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	46.56	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	67.70	1.60	1.60	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	63.79	0.82	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	62.20	1.55	0.00	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	41.97	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	49.67	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	75.31	1.19	0.00	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	56.05	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	53.84	0.63	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	51.39	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	49.43	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	59.88	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	44.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	52.97	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	52.43	0.79	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	48.34	1.18	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	49.56	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	49.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	47.31	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	35.95	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	68.15	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	54.43	3.46	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	54.95	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	61.70	0.64	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	70.93	2.42	0.81	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	80.68	8.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	76.02	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	75.86	0.00	0.00	1.82
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	90.38	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	51.89	1.65	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	66.27	0.79	0.99	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	52.24	2.60	0.32	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	64.17	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	120.70	1.55	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	122.85	2.60	1.65	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	137.61	3.01	0.93	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	55.56	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	91.04	0.92	0.10	0.51
mesothelioma cell line:Mero-25	10850-111F4	77.39	2.04	0.00	0.68
mesothelioma cell line:Mero-41	10851-111F5	91.92	0.73	0.24	1.22
mesothelioma cell line:Mero-48a	10852-111F6	118.47	3.10	0.89	0.22
mesothelioma cell line:Mero-82	10853-111F7	65.18	0.26	0.79	0.26
mesothelioma cell line:Mero-83	10854-111F8	57.70	0.51	0.68	0.51
mesothelioma cell line:Mero-84	10855-111F9	47.27	1.01	0.51	0.25
mesothelioma cell line:Mero-95	10856-111G1	110.56	1.66	1.24	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	101.54	1.82	0.50	0.83
mesothelioma cell line:NCI-H226	10846-111E9	56.83	1.09	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	53.98	0.51	0.68	0.17
mesothelioma cell line:NCI-H28	10845-111E8	55.73	1.27	0.25	0.25
mesothelioma cell line:No36	10857-111G2	70.79	0.33	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	97.00	1.35	0.54	0.27
migratory langerhans cells, donor1	11901-125F2	68.32	0.96	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	84.99	0.24	0.12	0.37
migratory langerhans cells, donor3	11903-125F4	90.64	0.00	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	93.05	0.98	0.00	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	75.45	0.64	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	70.95	1.38	0.46	1.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	47.95	0.00	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	116.23	1.29	0.37	0.74
myeloma cell line:PCM6	10474-106I6	68.20	0.20	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	78.12	0.00	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	101.60	2.35	0.78	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	32.65	0.33	0.00	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	31.77	0.81	0.22	0.59
nasal epithelial cells, donor2	12227-129F4	99.36	1.10	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	196.93	4.14	2.99	0.46
neuroblastoma cell line:NB-1	10539-107G8	93.54	6.55	1.68	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	90.68	1.05	0.42	0.42
neuroblastoma cell line:NH-12	10555-107I6	78.64	1.30	0.37	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	82.08	1.42	1.19	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	106.91	3.64	0.63	1.74
neuroectodermal tumor cell line:TASK1	10774-110F9	58.77	1.61	1.41	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	60.40	1.27	0.00	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	77.45	1.06	0.00	1.33
neutrophil PMN, donor1	12133-128D9	1665.98	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	172.65	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	265.18	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	196.01	0.34	0.85	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	111.27	2.40	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	69.89	2.56	0.32	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	66.22	0.26	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	126.92	6.28	1.50	1.50
occipital cortex - adult, donor10196	10172-103C1	115.38	2.06	0.00	4.12
occipital cortex, adult, donor10252	10163-103B1	137.67	3.22	0.54	0.54
occipital cortex, newborn, donor10223	10355-105E4	70.97	6.55	2.55	1.46
occipital lobe, adult, donor1	10076-102A4	93.15	3.67	0.79	1.84
occipital lobe, fetal, donor1	10073-102A1	138.60	6.87	4.29	6.01
occipital pole, adult, pool1	10036-101E9	109.75	5.12	1.66	1.42
olfactory region, adult	10195-103E6	96.10	2.87	1.34	1.34
optic nerve, donor1	10277-104E7	268.14	0.00	0.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	102.52	2.73	0.68	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	89.71	0.55	0.69	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	66.04	0.85	0.34	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	60.64	0.58	0.00	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	72.61	1.76	0.59	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	173.79	1.87	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	103.91	1.91	1.06	0.42
ovary, adult, pool1	10020-101D2	64.03	1.57	0.44	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	75.53	1.28	0.55	0.00
pancreas, adult, donor1	10049-101G4	96.89	3.76	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	68.21	0.56	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	94.89	2.73	1.19	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	89.58	1.82	0.66	1.16
paracentral gyrus, adult, pool1	10035-101E8	114.40	5.86	1.65	2.47
parietal cortex, adult, donor10258	10373-105G4	92.48	0.73	1.47	0.73
parietal lobe - adult, donor10196	10171-103B9	109.10	2.82	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	111.16	2.00	1.71	0.86
parietal lobe, adult, pool1	10034-101E7	132.09	4.93	1.41	1.67
parietal lobe, fetal, donor1	10072-101I9	130.93	5.82	2.91	1.94
parietal lobe, newborn, donor10223	10356-105E5	66.17	5.61	1.50	1.87
parotid gland, adult	10199-103F1	91.88	0.62	1.23	0.62
penis, adult	10200-103F2	68.75	0.54	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	80.88	4.09	2.23	2.05
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	62.65	0.29	0.44	0.58
pineal gland - adult, donor10196	10179-103C8	120.62	0.00	0.00	1.29
pineal gland, adult, donor10252	10160-103A7	167.60	3.55	0.59	1.18
pineal gland, adult, donor10258	10377-105G8	116.64	3.76	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	193.25	7.08	1.01	2.02
pituitary gland, adult, donor10252	10162-103A9	261.11	6.78	5.21	4.69
pituitary gland, adult, donor10258	10378-105G9	197.49	2.55	2.55	4.26
placenta, adult, pool1	10021-101D3	122.88	3.01	1.18	1.18
plasma cell leukemia cell line:ARH-77	10840-111E3	52.84	0.93	0.00	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	98.36	2.49	1.71	0.78
pons, adult, pool1	10033-101E6	126.09	8.52	1.20	2.15
postcentral gyrus, adult, pool1	10032-101E5	113.24	5.75	1.74	2.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	847.02	12.55	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	115.67	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	117.36	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	58.26	0.87	0.15	0.15
prostate cancer cell line:PC-3	10439-106E7	145.75	3.81	1.27	1.09
prostate, adult, pool1	10022-101D4	70.83	1.72	0.18	0.45
putamen, adult, donor10196	10176-103C5	97.73	4.25	0.24	1.65
putamen, adult, donor10252	10152-102I8	158.82	5.88	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	45.90	2.19	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	55.81	3.38	1.21	0.97
putamen, newborn, donor10223	10365-105F5	43.48	3.00	1.50	1.50
rectal cancer cell line:TT1TKB	10469-106I1	69.24	1.75	0.29	0.29
rectum, fetal, donor1	10067-101I4	133.54	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	121.48	1.27	0.64	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	75.39	1.24	0.00	0.83
retina, adult, pool1	10030-101E3	103.87	1.89	1.59	1.09
retinoblastoma cell line:Y79	10475-106I7	117.95	1.82	1.04	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	61.60	0.25	0.00	0.98
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	84.64	1.12	0.28	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	118.98	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	60.21	0.65	0.32	0.81
salivary acinar cells, donor2	11772-123I8	61.96	0.83	0.28	0.28
salivary acinar cells, donor3	11773-123I9	100.63	1.99	0.00	0.00
salivary gland, adult, pool1	10093-102C3	129.83	0.00	0.57	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	62.47	2.02	0.59	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	68.77	1.41	0.71	0.35
seminal vesicle, adult	10201-103F3	95.76	2.12	1.06	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	36.44	0.97	0.24	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	60.39	0.75	0.25	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	73.26	1.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	132.98	2.69	0.67	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	86.43	1.44	0.55	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	42.58	1.03	0.13	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	97.89	2.13	0.71	2.84
skeletal muscle, adult, pool1	10023-101D5	87.19	1.68	0.72	1.92
skeletal muscle, fetal, donor1	10066-101I3	83.42	0.00	1.01	1.01
skin, adult, donor1	10074-102A2	61.07	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	104.15	4.42	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	141.08	2.33	2.00	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	160.75	5.36	1.58	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	63.99	2.12	2.31	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	66.26	0.99	0.49	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	129.16	1.93	0.48	1.61
small cell lung carcinoma cell line:WA-hT	10562-108A4	82.15	0.22	0.00	0.65
small intestine, adult, pool1	10024-101D6	110.96	1.79	0.72	0.12
small intestine, fetal, donor1	10064-101I1	64.86	1.23	0.49	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	116.94	1.54	0.51	1.03
smooth muscle, adult, pool1	10048-101G3	60.22	0.78	0.52	1.29
somatostatinoma cell line:QGP-1	10781-110G7	114.71	1.88	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	97.73	2.06	0.46	2.06
spinal cord, adult, donor10252	10159-103A6	117.89	1.97	0.00	1.18
spinal cord, adult, donor10258	10369-105F9	93.39	1.38	0.00	1.38
spinal cord, fetal, donor1	10056-101H2	125.63	4.88	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	158.43	6.89	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	79.01	2.39	0.75	0.75
spleen, adult, pool1	10025-101D7	77.20	0.55	0.33	0.66
spleen, fetal, pool1	10044-101F8	122.92	0.72	0.64	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	54.03	0.52	0.31	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	38.92	0.57	0.38	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	70.24	1.40	0.70	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	92.26	1.56	1.17	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	116.50	2.59	1.01	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	86.41	1.69	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	35.11	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	153.79	0.00	2.14	0.00
submaxillary gland, adult	10202-103F4	118.49	1.14	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	154.74	1.66	0.00	0.83
substantia nigra, adult, donor10258	10371-105G2	102.42	1.55	1.55	0.52
substantia nigra, newborn, donor10223	10358-105E7	96.09	0.71	1.41	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	109.13	3.44	0.46	0.92
temporal lobe, adult, pool1	10031-101E4	130.89	5.59	2.20	2.37
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	145.30	13.53	2.14	3.56
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	112.52	4.83	2.64	2.64
tenocyte, donor1	11763-123H8	76.45	1.40	0.00	0.35
tenocyte, donor2	11765-123I1	59.51	0.38	0.00	0.00
tenocyte, donor3	11768-123I4	54.12	0.74	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	84.30	1.53	0.68	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	100.20	0.31	0.62	0.15
teratocarcinoma cell line:PA-1	10807-111A6	76.40	0.93	0.31	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	74.77	2.29	0.76	1.27
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	141.44	2.65	1.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	122.80	0.76	0.76	0.98
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	94.13	1.30	0.33	0.65
testis, adult, pool1	10026-101D8	90.62	1.72	0.75	1.40
testis, adult, pool2	10096-102C6	111.87	1.80	0.00	3.61
thalamus - adult, donor10196	10168-103B6	151.25	4.42	0.00	2.21
thalamus, adult, donor10252	10154-103A1	146.12	2.19	0.31	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	72.36	1.54	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	73.12	2.96	1.65	1.15
thalamus, newborn, donor10223	10366-105F6	70.76	5.75	1.73	1.73
throat, adult	10209-103G2	84.14	1.25	0.50	0.50
throat, fetal, donor1	10061-101H7	85.62	2.74	0.61	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	85.45	1.79	0.99	0.79
thymus, adult, pool1	10027-101D9	142.26	1.39	0.89	0.50
thymus, fetal, pool1	10043-101F7	224.02	1.45	0.94	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	112.48	0.93	0.53	0.93
thyroid carcinoma cell line:TCO-1	10783-110G9	75.43	0.84	0.56	0.70
thyroid, adult, pool1	10028-101E1	90.05	2.05	0.65	0.75
thyroid, fetal, donor1	10060-101H6	104.94	2.64	0.79	1.58
tongue epidermis (fungiform papillae), donor1	10288-104F9	141.66	3.08	0.00	0.00
tongue, adult	10203-103F5	57.21	0.93	0.23	0.70
tongue, fetal, donor1	10059-101H5	48.47	1.97	1.58	0.79
tonsil, adult, pool1	10047-101G2	120.81	1.40	0.30	0.70
trachea, adult, pool1	10029-101E2	71.00	0.90	0.41	0.49
trachea, fetal, donor1	10058-101H4	93.87	1.54	0.00	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	62.71	1.77	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	117.12	2.13	0.61	1.22
transitional-cell carcinoma cell line:JMSU1	10492-107B6	106.86	1.57	0.00	1.41
tridermal teratoma cell line:HGRT	10694-109G1	138.88	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	89.39	2.45	0.85	1.27
umbilical cord, fetal, donor1	10057-101H3	62.60	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	123.88	0.68	0.85	0.34
uterus, fetal, donor1	10055-101H1	103.41	1.02	1.54	0.51
vagina, adult	10204-103F6	62.04	0.00	0.00	0.65
vein, adult	10191-103E2	89.65	0.44	0.22	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	47.27	0.27	0.00	0.00